Miao W - Search Results

1

Lead identification of 2-iminobenzimidazole antagonists of the chemokine receptor CXCR3.

Hayes ME, Breinlinger EC, Wallace GA, Grongsaard P, Miao W, McPherson MJ, Stoffel RH, Green DW, Roth GP. Hayes ME, et al. Among authors: miao w. Bioorg Med Chem Lett. 2008 Apr 1;18(7):2414-9. doi: 10.1016/j.bmcl.2008.02.049. Epub 2008 Feb 26. Bioorg Med Chem Lett. 2008. PMID: 18337097

2

Synthesis and biological evaluation of imidazole-based small molecule antagonists of the melanocortin 4 receptor (MC4-R).

Marsilje TH, Roses JB, Calderwood EF, Stroud SG, Forsyth NE, Blackburn C, Yowe DL, Miao W, Drabic SV, Bohane MD, Daniels JS, Li P, Wu L, Patane MA, Claiborne CF. Marsilje TH, et al. Among authors: miao w. Bioorg Med Chem Lett. 2004 Jul 16;14(14):3721-5. doi: 10.1016/j.bmcl.2004.05.003. Bioorg Med Chem Lett. 2004. PMID: 15203150

3

Discovery of small molecule benzimidazole antagonists of the chemokine receptor CXCR3.

Hayes ME, Wallace GA, Grongsaard P, Bischoff A, George DM, Miao W, McPherson MJ, Stoffel RH, Green DW, Roth GP. Hayes ME, et al. Among authors: miao w. Bioorg Med Chem Lett. 2008 Mar 1;18(5):1573-6. doi: 10.1016/j.bmcl.2008.01.074. Epub 2008 Jan 26. Bioorg Med Chem Lett. 2008. PMID: 18242988

4

Potent and selective TYK2-JH1 inhibitors highly efficacious in rodent model of psoriasis.

Leit S, Greenwood JR, Mondal S, Carriero S, Dahlgren M, Harriman GC, Kennedy-Smith JJ, Kapeller R, Lawson JP, Romero DL, Toms AV, Shelley M, Wester RT, Westlin W, McElwee JJ, Miao W, Edmondson SD, Masse CE. Leit S, et al. Among authors: miao w. Bioorg Med Chem Lett. 2022 Oct 1;73:128891. doi: 10.1016/j.bmcl.2022.128891. Epub 2022 Jul 13. Bioorg Med Chem Lett. 2022. PMID: 35842205

5

Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.

King PJ, Ma G, Miao W, Jia Q, McDougall BR, Reinecke MG, Cornell C, Kuan J, Kim TR, Robinson WE Jr. King PJ, et al. Among authors: miao w. J Med Chem. 1999 Feb 11;42(3):497-509. doi: 10.1021/jm9804735. J Med Chem. 1999. PMID: 9986720

6

Selective interleukin-1 receptor-associated kinase 4 inhibitors for the treatment of autoimmune disorders and lymphoid malignancy.

Kelly PN, Romero DL, Yang Y, Shaffer AL 3rd, Chaudhary D, Robinson S, Miao W, Rui L, Westlin WF, Kapeller R, Staudt LM. Kelly PN, et al. Among authors: miao w. J Exp Med. 2015 Dec 14;212(13):2189-201. doi: 10.1084/jem.20151074. Epub 2015 Nov 30. J Exp Med. 2015. PMID: 26621451 Free PMC article.

7

Anti-leukaemic activity of the TYK2 selective inhibitor NDI-031301 in T-cell acute lymphoblastic leukaemia.

Akahane K, Li Z, Etchin J, Berezovskaya A, Gjini E, Masse CE, Miao W, Rocnik J, Kapeller R, Greenwood JR, Tiv H, Sanda T, Weinstock DM, Look AT. Akahane K, et al. Among authors: miao w. Br J Haematol. 2017 Apr;177(2):271-282. doi: 10.1111/bjh.14563. Epub 2017 Mar 14. Br J Haematol. 2017. PMID: 28295194 Free PMC article.

8

Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study.

Stiede K, Miao W, Blanchette HS, Beysen C, Harriman G, Harwood HJ Jr, Kelley H, Kapeller R, Schmalbach T, Westlin WF. Stiede K, et al. Among authors: miao w. Hepatology. 2017 Aug;66(2):324-334. doi: 10.1002/hep.29246. Epub 2017 Jul 5. Hepatology. 2017. PMID: 28470676 Free PMC article. Clinical Trial.

9

Inhibition of Acetyl-CoA Carboxylase by Phosphorylation or the Inhibitor ND-654 Suppresses Lipogenesis and Hepatocellular Carcinoma.

Lally JSV, Ghoshal S, DePeralta DK, Moaven O, Wei L, Masia R, Erstad DJ, Fujiwara N, Leong V, Houde VP, Anagnostopoulos AE, Wang A, Broadfield LA, Ford RJ, Foster RA, Bates J, Sun H, Wang T, Liu H, Ray AS, Saha AK, Greenwood J, Bhat S, Harriman G, Miao W, Rocnik JL, Westlin WF, Muti P, Tsakiridis T, Harwood HJ Jr, Kapeller R, Hoshida Y, Tanabe KK, Steinberg GR, Fuchs BC. Lally JSV, et al. Among authors: miao w. Cell Metab. 2019 Jan 8;29(1):174-182.e5. doi: 10.1016/j.cmet.2018.08.020. Epub 2018 Sep 20. Cell Metab. 2019. PMID: 30244972 Free PMC article.

10

MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL.

Improgo MR, Tesar B, Klitgaard JL, Magori-Cohen R, Yu L, Kasar S, Chaudhary D, Miao W, Fernandes SM, Hoang K, Westlin WF, Kim HT, Brown JR. Improgo MR, et al. Among authors: miao w. Br J Haematol. 2019 Mar;184(6):925-936. doi: 10.1111/bjh.15714. Epub 2018 Dec 9. Br J Haematol. 2019. PMID: 30537114 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,201 results

Search Page

Filters